2023 PERT Consortium Annual Meeting Agenda

2023 PERT Agenda

See Agenda for Friday, September 22
See Agenda for Saturday, September 23

Wednesday, September 20

Physicians-in-Training Bootcamp
Annual Business Meeting
Annual Industry Meeting

Thursday, September 21

8:00am – 8:40am
Welcome & Keynote

8:30am – 9:30am
Epidemiology of PE, Racial and Gender Disparities
Epidemiology and Worldwide Burden of PE: Insights from Registries
Gender Based Disparities in PE Care
Race Based Disparities in PE Care
Q & A

9:30am – 10:30am
Diagnosis and Risk Stratification

PE Pathophysiology: What Are We Dealing With?
CT and Other Imaging in the Diagnosis: What’s New
Echo: Where Does it Fit in and What is The Role of POCUS
Risk Stratification: Refining Our Approaches
Q & A 

11:00am – 12:00pm
New Consortium Initiatives: Moving the Needle Forward
Update on PERC/USFDA
PERT Database 2.0
USFDA Perspective on the PE Space
Centers of Excellence in PE Care: Introduction
Q & A

12:00pm – 1:00pm

1:15 – 2:15pm

A. Why, When and How to Start a PERT – Roundtable Discussion

B. Diagnostic Evaluation: Case Based Discussion
Challenges in Risk Stratification:  Role for Gestalt?
Point of Care Echo:  How to do it, What to Look For

C. ICU Considerations
General ICU Care of the Sick PE Patient: How I do it?
Pharmacologic Support: What to Give, When to Give it
Mechanical Circulatory Support: Practical Considerations Discussion

D. Centers of Excellence in PE Care: What You Should Know
Why are COEs Important
Process and Criteria for COE Certification
Value Proposition in Becoming a COE Discussion

Oral Abstract Presentations
Presentation 1
Presentation 2
Presentation 3
Q & A

3:30pm – 4:15pm
Patient Perspective

4:15pm – 5:15pm
PE Game Show

5:15pm – 7:15pm
Posters & Cocktail Reception

Friday, September 22

8:00am – 8:30am
Welcome Day 2

8:30am – 9:30am
Medical Management: It’s Not Always About Devices!
Case Presentation
Outpatient vs. Inpatient Care
Anticoagulation Options: What are The Data?
Screening for Thrombophilia: Yes, No or Maybe?
Q & A

9:30 – 10:30am
Blackhawk Down: Treating the ‘Big One’
Case Presentation
What is “High Risk”?:  Not Always Clear
MCS:  A Plumbing Lesson
Pro:  Surgical Embolectomy is the Treatment of Choice for High-Risk Patients
Con:  High Risk Patients Should be Treated Non-Surgically
Q & A

11:00am – 12:00pm
The Catheters! What Would I Choose in This Case?
Case Presentation
Catheter Directed Thrombolysis is My Choice
Aspiration Thrombectomy is My Choice
Hybrid Approach is My Choice
On the Horizon in Catheter Technology
Q & A


1:15pm – 2:15pm
Clinical Trials in PE: New Data Coming Soon!
Q & A

2:30pm – 3:30pm

E. Balloon Pulmonary Angioplasty: Tips of the Trade
Selection of Patients for BPA
Procedural Approach
Follow up, When to Stop

F. MCS Workshop
ECMO: Who? What? When? Where?
Percutaneous Right Ventricular Assist Device (RVAD)
Pathophysiology Justification of Mechanical Circulatory Support (MCS)
Ideal Timing of MCS

G. It all Started in The Leg
Post-Thrombotic Syndrome
Inferior Vena Caval Thrombosis
Clot in Transit

3:45pm – 4:45pm
Best Papers of the Year
Presentation 1
Presentation 2
Presentation 3
Q & A

Saturday, September 23

8:00am – 8:10am
Welcome Day 3

8:10am – 9:10am
After the Clot: What Now?
Post-PE Clinic:  Why is it Important, What is Done There?
Post-PE Syndrome: What is it? How Do We Diagnose It?
Periprocedural Considerations
Anticoagulation Duration: Are Predictive Equations Useful?
Q & A

9:10am – 10:10am
CTEPH and CTED: Treatable, Under-diagnosed
Epidemiology of CTEPH and CTED
Diagnostic Approach
Pulmonary Thromboendarterectomy: What Is It? What are the Data?
Balloon Pulmonary Angioplasty: An Option for Some Patients
Medical Therapy for CTEPH/CTED
Q & A

11:30am – 12:30pm
Special Populations
Sickle Cell
Q & A

11:30am – 12:30pm
Great Case! Our Most Notable Saves and Toughest Complications
Case 1
Case 2
Case 3
Case 4
Q & A

Meeting Adjourned